Sunday, December 22, 2024

Healthcare

The Future of Cancer Therapy is Here

RenovoRx's TAMP™ technology delivers chemotherapy directly to tumors, reducing side effects and improving treatment efficacy. With a projected 330% price increase, RenovoRx is gaining investor...

Advancing Neurological Solutions with Game-Changing Science

Bright Minds Biosciences Inc. (NASDAQ: DRUG) is a biotechnology company focused on developing novel therapies for neurological and neuropsychiatric disorders, such as healing the central nervous...

Investing in Biotech: Why 2024 Could Be the Year of Major Gains

2024 sees a biotech rebound, with over 15 IPOs by mid-year and capital inflows increasing across the sector. Gene therapy and oncology are driving biotech...

Bright Minds Targets Epilepsy with Breakthrough 5-HT2C Agonist

Bright Minds Biosciences launches a Phase 2 trial for BMB-101, targeting drug-resistant epilepsy with high unmet needs. The company trades at a $5M market cap,...

A Closer Look at NurExone: Exosome Innovation with Long-Term Potential (TSXV: NRX, OTCQB: NRXBF)

NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company developing regenerative medicine therapies. NurExone chose to base its...

Popular

Subscribe